Here are four things to know:
1. The proposed rule will not only set drug price ceilings for the 340B program, but will also grant HHS authority to fine drugmakers for overcharging hospitals.
2. Since its introduction in 2010, the proposed rule has been delayed five times. Most recently, the rule was set to take effect July 1, 2019.
3. However, on Oct. 31 HHS announced plans to “cease any further delay of the rule and change the effective date to Jan. 1, 2019.”
4. CMS is accepting comments through Nov. 24 on the new implementation date for the 340B ceiling price rule.
Access the full notice of proposed rulemaking here.
More articles on healthcare finance:
Spending on California ballot initiatives over hospital charges exceeds $10M
California spent $4B on Medi-Cal coverage for potentially ineligible people, audit finds
Mississippi hospitals end Medicare Advantage agreements over declining reimbursement
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
